J. Goldman & Co LP - EVOKE PHARMA INC ownership

EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 21 filers reported holding EVOKE PHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q1 2018$52,000
-8.8%
25,0000.0%0.00%
-33.3%
Q4 2017$57,00025,0000.00%
Other shareholders
EVOKE PHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 175,000$448,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 500,000$1,280,0000.22%
PRECEPT MANAGEMENT LLC 95,000$243,0000.15%
Family Management Corp 10,425$27,0000.02%
STATE OF MICHIGAN RETIREMENT SYSTEM 400,000$1,024,0000.01%
Acrospire Investment Management LLC 2,489$6,0000.01%
A.R.T. Advisors, LLC 15,413$39,0000.00%
NORTHERN TRUST CORP 29,214$75,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 23,048$59,0000.00%
DEUTSCHE BANK AG\ 200$00.00%
View complete list of EVOKE PHARMA INC shareholders